Organization | Chest Department, Taipei VGH

Chest Department, Taipei VGH Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial

2005

NCT01037998

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2008

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (4)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

paclitaxel (taxol) (1 trial)

pemetrexed (alimta) (1 trial)

Drugs in Phase 2 Trials (3)

gefitinib (iressa) (1 trial)

tegafur (1 trial)

uracil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma, Non-Small-Cell Lung (Phase 4)

Lung Neoplasms (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 7